Wei Xu

Nanchang University

H指数:17

被引数:767

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

P2X2/3 receptors as a potential target for cancer pain treatment

P2X2/3受体作为癌症疼痛治疗的潜在靶点

Behavioural Brain Research

IF2.3

2026-03-060

PRE

Genetic basis of Pseudonectria foliicola infection in humans and research on DKP-type natural products

假丝链格孢菌叶枝孢（Pseudonectria foliicola）感染人类的遗传基础及DKP型天然产物的研究

BMC Genomics

IF3.7

2026-02-180

OAAI

A haplotype-resolved genome assembly of Anoectochilus roxburghii

一份Anoectochilus roxburghii的相合型解析基因组组装

Scientific Data

IF6.9

2025-12-030

OAAI

SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer

SLC7A5-ERBB2轴通过从头脂质合成驱动卵巢癌奥拉帕尼耐药性

Oncogene

IF7.3

2025-11-280

OAAI

Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances

极性蛋白Par6：解析其在肿瘤发生发展中的机制与研究进展

Cellular Signalling

IF3.7

2025-10-170

PRE

Deciphering the allosteric dynamics of GPR120-fatty acid interactions within a bilayer nanogold electrochemical receptor biosensor: the impact of replacing tryptophan 198 with proline

BIOMEDICAL MICRODEVICES

IF3.3

2025-03-010

PRE

A Peptide Nanoregulator Enriched at the Endoplasmic Reticulum for Boosting Fractionated Radiotherapy-Mediated Antitumor Immune Response

一种富集于内质网的肽纳米调节剂，用于增强分次放射疗法介导的抗肿瘤免疫反应

ADVANCED FUNCTIONAL MATERIALS

IF19

2025-01-140

PRE

Recent Advances in the Quantitative Determination of Protein Receptor-Ligand Interaction Kinetics

CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY

IF5.2

2024-10-241

PRE

ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated Macrophages

肝癌细胞和肝星状细胞中的ASH1L通过调节肿瘤相关巨噬细胞促进纤维化相关肝细胞癌

ADVANCED SCIENCE

IF14.1

2024-10-080

miR-140-3p enhances the sensitivity of LUAD cells to antitumor agents by targeting the ADAM10/Notch pathway

JOURNAL OF CANCER

IF3.2

2022-01-018

OAAI

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma

TMED3/RPS15A轴促进骨肉瘤的发生发展

CANCER CELL INTERNATIONAL

IF6

2021-11-2712

OAAI

Association of the hOGG1 Ser326Cys polymorphism with gynecologic cancer susceptibility: a meta-analysis

BIOSCIENCE REPORTS

IF4.7

2020-11-265

OAAI

Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-KB pathway

ARCHIVES OF MEDICAL SCIENCE

IF3.3

2019-07-224

OAAI

Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition

EXPERIMENTAL EYE RESEARCH

IF2.7

2019-07-0119

PREAI

RETRACTED: Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells (Retracted article. See vol. 150, 2022)

撤回: 淫羊藿苷通过下调甲状腺癌细胞中的microRNA-625-3p来抑制细胞增殖，迁移和侵袭 (撤回的文章。见150卷，2022)

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-01-0136

OAAI

miR-107-5p promotes tumor proliferation and invasion by targeting estrogen receptor-α in endometrial carcinoma

ONCOLOGY REPORTS

IF3.9

2018-12-1828

OAAI

PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer

DRUG DELIVERY

IF8.1

2018-11-0333

OAAI

Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2

CALCIFIED TISSUE INTERNATIONAL

IF3.2

2018-05-0267

PREAI

Dickkopf 2 promotes proliferation and invasion via Wnt signaling in prostate cancer

MOLECULAR MEDICINE REPORTS

IF3.5

2016-07-1121

OAAI

Antitumor effect of F-PBFβ-TrCP-induced targeted PTTG1 degradation in HeLa cells

JOURNAL OF BIOTECHNOLOGY

IF3.9

2009-01-019

PREAI

Wei Xu

个人简介

教育背景

工作经历

荣誉奖项

研究方向